This study investigated the role of IL-1β-511 (rs16944), TLR4-896 (rs4986790) and TNF-α-308 (rs1800629) polymorphisms in type 2 diabetes mellitus (T2DM) among an endogamous Northern Indian population. Four hundred fourteen participants (204 T2DM patients and 210 nondiabetic controls) were genotyped for IL-1β-511, TLR4-896 and TNF-α-308 loci. The C allele of IL-1β-511 was shown to increase T2DM susceptibility by 75% (OR: 1.75 [CI 1.32-2.33]). Having two parents affected by T2DM increased susceptibility by 5.7 times (OR: 5.693 ). In this study, we have demonstrated a conclusive association with IL-1β-511 locus and IL-1β-511-TLR4-896 diplotype (CC-AA) and T2DM, which warrants further comprehensive analyses in larger cohorts.
Introduction
South Asians' are approximately five times more likely to develop T2DM, and its comorbidities, at an earlier age than white Europeans (Ramachandran et al., 2012) . There are an estimated 65 million cases of T2DM in India, which will double within the next two decades (Ramachandran et al., 2012) .
T2DM is a complex metabolic condition characterised by an individual's inability to regulate blood sugar levels, resulting in hyperglycaemia. T2DM is caused due to either a lack of insulin production from the pancreas or the body's tissues developing a resistance to insulin, and it is normally preceded by low-grade inflammation and the release of inflammatory cytokines (Cruz et al., 2013) . Inflammation and its pathways have been targeted in recent research on pathology and treatment of the disease among other gene targets (Brunetti et al., 2014; Goldfine and Shoelson, 2017) .
The toll-like receptor 4 (TLR4) protein is responsible for the mediation of immune responses and inflammation activa-tion (Takeda et al., 2003) . Interleukin-1β (IL-1β), a proinflammatory cytokine, protects against infection and stimulates neutrophils and macrophages to initiate phagocytosis (Netea et al., 2010) . Tumor necrosis factor alpha (TNF-α) is another proinflammatory cytokine involved in the recovery from tissue damage, infection, and facilitates the movement of immune cells to defective tissues (Barbara et al., 1996) .
Preclinical studies indicate TNF-α induces insulin resistance (Hotamisligil et al., 1993) , and there is some evidence that TNF-α inhibitors reduce glycaemia, fasting glucose levels and diabetes incidence (Stanley et al., 2011; Goldfine and Shoelson, 2017) . Preclinical and clinical studies also report IL-1β involvement in T2DM pathogenesis (Koenen et al., 2011; Sloan-Lancaster et al., 2013) . The antagonist IL-1Ra inhibits IL-1β signalling and alleviated systemic inflammation and glycaemia in T2DM patients (Larsen et al., 2007) . The expression of TLR4, IL-1β and TNF-α is also modulated by glucagon-like peptide-1 receptor agonist (Exenatide) among diabetics (Chaudhuri et al., 2011) . This provides a rationale for the candidate genes featuring in this study to be investigated as they have the potential to form future drug targets for T2DM therapy.
IL-1β-511 (rs16944:T>C), TLR4-896 (rs4986790:A>G) and TNF-α-308 (rs1800629:G>A) polymorphisms are associated with T2DM in European, Mexican, Moroccan and Indian populations (Achyut et al., 2007; Assman et al., 2014; Sefri et al., 2014; Saxena et al., 2015 and Tripathi et al., 2015) , although studies on Indian populations are limited. Genetic analyses of inflammatory genes contribute to the development of prognostic markers, which could be used to distinguish individuals at risk. Therefore, it will be beneficial to conduct comprehensive studies on Indian subpopulations to disentangle the genetic burden of T2DM. This study aims to investigate the association of IL-1β-511, TLR4-896 and TNF-α-308 polymorphisms with T2DM in an endogamous Northern Indian population.
Materials and Methods

Study Subjects
This study consisted of 204 T2DM patients (104 males and 100 females) and 210 nondiabetic unrelated controls (87 males and 123 females). Participants belong to the endogamous group of Lobana Sikhs-an agriculturist population from Punjab, North India, and were sampled in early 1990s as part of ongoing genetic and disease studies (Mastana et al., 2013) . Samples were collected from unrelated patients and controls after obtaining written informed consent. T2DM status was diagnosed by either a medical record or tests showing fasting glucose levels [7.0 mmol/L or [126 mg/dL after a minimum 12-h fast or 2-h post glucose level (oral glucose tolerance test or 2-h OGTT) [11.1 mmol/L or 200 mg/dL] on more than one occasion. Control participants were free of diabetes symptoms and were matched to the patients for age, gender and geographical location. The current study was approved by the ethics committees of local medical hospitals and colleges and Loughborough University. Further details of clinical/diagnostic and demographic features of these samples are given in a previous study (Mastana et al., 2013) .
Genotyping
IL-1β-511 (rs16944) polymorphism was amplified and analysed using the PCR-restriction fragment length polymorphism method (PCR-RFLP) (Mirowska-Guzel et al., 2011) . TLR4-896 (rs4986790) and TNF-α-308 (rs1800629) polymorphisms were genotyped using TaqMan R assays (Assay ID C__11722238_20 and C___7514879_10, respectively). Ten percent of samples were repeated to check genotyping reliability.
Statistical Analysis
Continuous variables were compared using means and standard deviations (unpaired t-tests 
Results
Demographics
The anthropometrical, biochemical and clinical characteristics of the patient and control populations are summarised in Table 1 . Patients, on average, were taller and heavier than controls, with larger waist and hip measurements and a larger waist-hip ratio. Systolic blood pressure (SBP) was shown to be significantly higher in patients. High-density lipoprotein (HDL) levels were lower in patients than the controls (P < 0.005).
Genotype and Allele Distribution
The distribution of different genotypes and alleles within patients and controls are presented in Table 2 , along with synergistic effects at diplotype and triplotype combinations. Both patients and controls were within HWE for IL-1β-511 and TLR4-896. At TNF-α-308 locus, only the patients were in HWE (χ 2 = 3.539), and controls violated the HWE even after Bonferroni correction (χ 2 =8.328). The frequency of the IL-1β-511 CC genotype was higher in patients (19.8%) than in controls (10.4%). The C allele of IL-1β-511 increases the risk of T2DM by about 75% (OR: 1.75 [CI 1.32-2.33]) while T allele exerted a protective effect (OR: 0.57 ).
TLR4-896 genotype distribution was similar between patients and controls. Neither A or G allele of TLR4-896 had a statistically significant association with the disease.
At TNF-α-308 locus, 89.9% of patients and 92.6% of controls possessed the most common GG genotype, whereas the frequency of the rare AA genotype was similar in both groups (1%). TNF-α-308 also showed no statistically significant allelic or genotypic association with T2DM, though heterozygote GA genotype increased the risk by 47% (OR: 1.47 .09]). 
Synergistic Effect
The synergistic effect of genotypic combinations is presented in Table 2 . Four diplotype and three triplotype combinations were statistically significant before the Bonferroni correction. After the correction, only IL-1β-511-TLR4-896 diplotype combination CC-AA remained significantly associated with T2DM, although mean glucose levels did not present a statistically significant difference when compared to the reference genotype (TT-AA).
Binary Logistic Regression
Binary logistic regression analysis was carried out at two levels; in genotype-only analysis (Table 3) , ORs and associated significance values were broadly similar to the analyses given in Table 2 . Table 4 gives the results of a logistic regression analysis including selected demographic and clinical variables, where the IL-1β (CC genotype) remains a significantly susceptible genotype. TLR4 genotypes AG and GG change the direction of the effect and become susceptible. The regression analysis showed that having both parents affected by T2DM increases individual's risk by 5.7 times. Body mass index, SBP, DBP and HDL levels are all independent predictors of T2DM in this population.
Discussion
This is the first study on a well-characterised endogamous sample, analysing inflammatory genes for their association with T2DM. In this study, C allele of IL-1β-511 increased the likelihood of T2DM (OR: 1.75 [CI = 1.32-2.33]), while T allele exerted a protective effect (OR: 0.57 [CI = 0.43-0.76]), and the TC and CC genotypes increased T2DM risk Significant predictors of T2DM are indicated in bold. The present results contradict some previous studies where the T allele was associated with T2DM. (Achyut et al., 2007; Saxena et al., 2015 and Tripathi et al., 2015) . The previous studies are difficult to interpret due to ambiguity in genotyping methods. Two studies report the C allele to be 304bp and T allele 189 and 116 bp (Saxena et al., 2015 and Tripathi et al., 2015) . This study coded the alleles in the same manner as Mirowska-Guzel et al. (2011) and Achyut et al. (2007) (T:304 bp; C:190 + 114 bp). Genotyping calls in this study were also confirmed using a TaqMan R assay, which provides confidence in these results. The aforementioned publications analysed heterogeneous Indian populations recruited from outpatient clinics and hospitals; however, the present sample is from a field-based study on a homogenous and endogamous Sikh population (Mastana et al., 2013) .
Although statistically insignificant trends were observed for the A allele of the TNF-α-308 locus and G allele of TLR4-896 locus, further studies are warranted with larger samples to confirm/evaluate these associations (Sefri et al., 2014; Assman et al., 2014) .
The inconsistent results of IL-1β-511, TLR4-896 and TNF-α-308 association with T2DM across a range of populations suggests that ethnicity may play a role in how these genes interact with the disease. Populations from different geographical regions are exposed to different environmental risk factors, thus different gene-environment interactions are formed. This can alter how the genes influence T2DM in different populations, therefore producing inconclusive results.
IL-1β-511 seems to be the main contributor to susceptibility in the diplotype IL-1β-511-TLR4-896 (Table 2) , due to the increased risk associated with the C allele. The synergistic effect is not a purely additive model, and the increased susceptibility is attributable to the combination of independent risk alleles at both loci. IL-1β and TLR4 activity in macrophages can be suppressed by dipeptidyl peptidase-4 inhibitors, thus potentially having an antihyperglycaemic effect (Dai et al., 2014) . It is of great importance to conduct further preclinical/clinical studies on these candidate genes in order to develop drug therapies for T2DM (Chaudhuri et al., 2011; Goldfine and Shoelson, 2017) .
The regression analysis confirmed a significant independent association between T2DM and the IL-1β-511 CC genotype, family history of T2DM, BMI, SBP, DBP, and HDL levels. In this study, a positive family history presents the largest risk to offspring when both parents have T2DM (OR = 5.693, ). Maternal diabetes alone increased T2DM risk by 5.086 times, suggesting that maternal diabetes exerts a higher risk to offspring than paternal diabetes.
In this study, we have demonstrated a conclusive association with IL-1β and T2DM. IL-1β and TLR4 polymorphisms conclusively contribute to T2DM in a synergistic fashion. Research has also shown that the above polymorphisms have been targeted in drug development to reduce inflammation in diabetics; further population-focused interventions are required to improve gene-based treatments. Maternal diabetes is a strong independent determinant of T2DM in this population. Further comprehensive studies on different geographical populations are warranted with larger samples to clarify the role of inflammatory gene polymorphisms in T2DM in the Indian population.
